TABLE 6

Results of left ventricular function and eye examinations between baseline and 12-month visit

All
Type 1 diabetes
Type 2 diabetes
Vitamin EPlaceboVitamin EPlaceboVitamin EPlacebo
Septal wall thickness (mm)
    Baseline9.9 ± 1.510.7 ± 2.59.2 ± 1.210.4 ± 2.110.4 ± 1.611.0 ± 3.1
    Exit10.0 ± 1.710.7 ± 3.09.1 ± 1.510.5 ± 2.310.6 ± 1.710.9 ± 3.8
    PNSNSNSNSNSNS
Posterior wall thickness (mm)
    Baseline9.8 ± 1.39.8 ± 3.09.4 ± 1.19.3 ± 2.510.1 ± 1.510.4 ± 3.7
    Exit10.3 ± 1.910.0 ± 2.39.4 ± 1.59.8 ± 2.011.0 ± 2.010.3 ± 3.0
    PNSNSNSNSNSNS
Mitral valve E wave (m/s)
    Baseline0.84 ± 0.160.77 ± 0.250.82 ± 0.120.81 ± 0.250.85 ± 0.190.73 ± 0.26
    Exit0.83 ± 0.160.74 ± 0.260.75 ± 0.130.70 ± 0.290.88 ± 0.160.76 ± 0.25
    PNSNSNSNSNSNS
Mitral valve E/A ratio*
    Baseline1.19 ± 0.351.22 ± 0.541.29 ± 0.521.43 ± 0.781.13 ± 0.191.08 ± 0.26
    Exit1.08 ± 0.320.98 ± 0.321.16 ± 0.401.04 ± 0.451.03 ± 0.270.94 ± 0.22
    PNS0.055NSNS0.050.05
Average of both eyes
    Baseline3.1 ± 3.44.0 ± 3.73.5 ± 3.34.8 ± 3.42.9 ± 3.53.5 ± 4.0
    Exit4.0 ± 3.75.6 ± 4.54.4 ± 3.87.2 ± 4.03.8 ± 3.84.5 ± 4.6
    P0.050.05NSNSNSNS
  • Data are means ± SD unless otherwise indicated.

  • *

    * Mitral valve peak early (E) and late (A) transmitral filling velocities ratio.